The susceptibility of Pseudomonas aeruginosa strains from cystic fibrosis patients to bacteriophages.
Phage therapy may become a complement to antibiotics in the treatment of chronic Pseudomonas aeruginosa infection. To design efficient therapeutic cocktails, the genetic diversity of the species and the spectrum of susceptibility to bacteriophages must be investigated. Bacterial strains showing high...
Guardado en:
Autores principales: | Christiane Essoh, Yann Blouin, Guillaume Loukou, Arsher Cablanmian, Serge Lathro, Elizabeth Kutter, Hoang Vu Thien, Gilles Vergnaud, Christine Pourcel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bfee257388a24b4c8fcd67fbefcab8f7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A novel Pseudomonas aeruginosa bacteriophage, Ab31, a chimera formed from temperate phage PAJU2 and P. putida lytic phage AF: characteristics and mechanism of bacterial resistance.
por: Libera Latino, et al.
Publicado: (2014) -
Isolation and characterization of a lytic bacteriophage against Pseudomonas aeruginosa
por: Sonika Sharma, et al.
Publicado: (2021) -
Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone
por: Carla López-Causapé, et al.
Publicado: (2017) -
The role of Psl in the failure to eradicate Pseudomonas aeruginosa biofilms in children with cystic fibrosis
por: Amanda J. Morris, et al.
Publicado: (2021) -
Molecular analysis of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients
por: Dariusz Jarych, et al.
Publicado: (2021)